Diabetic NeuropathiesNCT07575126
Comparison of Qigong and Otago in Patient With Diabetic Neuropathy
A study testing Qigong Balance and Otago Balance in people with Diabetic Neuropathies, run by Riphah International University at 1 site in Pakistan.
Trial summary
This study seeks to compare these two interventions to better understand their impact on key health outcomes in patients affected by diabetic neuropathy, providing valuable insights for clinicians and healthcare providers managing this challenging condition Read more about this study
- Who is it for?
- Ages 45 to 65 years
- Conditions the study is for
- Diabetic Neuropathies
- What is being tested?
- Qigong Balance and Otago Balance
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 44 participants
- Where
- 1 sitePakistan
- Study dates
- 15 May 2026to 30 Aug 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Physician-diagnosed type 2 diabetes without gender bias, with peripheral neuropathy (defined by Michigan Neuropathy Screening Instrument questionnaire score of 5 or greater)
- Type 2 diabetic peripheral neuropathy patients
- The ability to walk independently for 10 m
- Having score between 46 to 52 (out of a total of 56 points) on the BBS
Who cannot join
- Fracture of the lower limb within the 6 months before the study (15)
- Diabetic ulcer, infection or partial amputation in feet (15)
- Disease or functional impairment of auditory, vestibular system (16)
- Any other medical conditions that would confound assessment of neuropathy such as malignancy, other neurological or orthopedic impairments (such as stroke, poliomyelitis, rheumatoid arthritis, prosthesis, or severe osteoarthritis), major vascular complications (venous or arterial ulcers), severe retinopathy, or severe nephropathy that causes edema or needs hemodialysis (17)
- Dementia or inability to give consistent information (18)
- History of surgical procedure at the knee, ankle, or hip or indication of surgery throughout the intervention period
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan1 site
DHQ Gujranwala
Chak One Hundred Seventy-five Nine Left, Punjab Province, 54500
Javeria Ghazal, MS, +923335154664
Junaid Raza, MS
About this study
Official title: Comparison of Qigong and Otago on Agility, Balance, Gait, and Quality of Life in Patients With Diabetic Neuropathy
This study seeks to compare these two interventions to better understand their impact on key health outcomes in patients affected by diabetic neuropathy, providing valuable insights for clinicians and healthcare providers managing this challenging condition
- Conditions
- Diabetic Neuropathies
- Being tested
- Qigong Balance, Otago Balance
- Medical subject headings
- Diabetic Neuropathies
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Qigong BalanceOther
Quigong Balance Exercises 3 times per week for 60 minutes per session Open the Flow: Focus on fluid arm movements to enhance relaxation and improve circulation.
Shaking Exercise: A full-body shake to release tension and promote energy flow. Lifting the Ball: Alternating arm movements simulating lifting a ball to improve upper body strength and coordination.
Playing with Water: Slow, flowing movements that enhance balance and mindfulness.
Weight Shifting and Balance Exercises: Stand with feet hip-width apart, shifting weight slowly from one leg to the other, holding each position for 10-15 seconds to engage stabilizing muscles in the legs and improve proprioception.
Leg Lifts and Extensions: Perform controlled leg lifts (front, side, and back) to strengthen the quadriceps, hamstrings, and hip abductors.
Otago BalanceOther
Otago (Strengthening) Balance:
Sit-to-stand exercises: to improve leg strength. Heel raises: to enhance calf strength. Toe stands: for improving foot stability.
Balance Training:
Single-leg stands: to enhance balance. Tandem walking: along a straight line. Side leg raises: to strengthen hip muscles 3 times per week for 60 minutes per session
| Study group | Role | What they receive |
|---|---|---|
| Qigong Balance | Experimental | Not described Receives: Other: Qigong Balance |
| Otago Balance | Active comparator | Not described Receives: Other: Otago Balance |
What is being measured
The primary outcome is the main question the study is designed to answer.
Agility T-Test
The Agility T-Test is a performance-based assessment that measures an individual's agility and ability to change direction quickly. It involves a sequence where the participant runs to a designated point, makes sharp turns around markers in a T-shaped layout, and returns to the starting position.
Measured: 12th week
Berg Balance Scale
is the gold standard test for static and dynamic balance abilities. The BBS is used to measure ability to maintain balance while doing functional task search as reach, standing position and transferences. It is a valid instrument used for the evaluation of effectiveness of interventions with quantitative description of function in clinical practice as well as research. It consists of 14 items including simple balance tasks from everyday life.
Measured: 12th week
Functional Reach Test
FRT is a single item test for dynamic balance and acts as a quick screen for balance problems in older adults. The distance between the lengths of an outstretched arm in a maximal forward reach, while maintaining a fixed base of support is measured. A score of 6 inches or less indicates a significant increased risk for falls. A score between 6-10 inches indicates a moderate risk for falls. the Functional Reach Test (FRT) demonstrates an ICC of approximately 0.85 to 0.94
Measured: 12th week
Gait Speed Test
The Gait Speed Test measures the time it takes for an individual to walk a specific distance, usually 10 meters, at their usual pace. It has demonstrated strong validity and reliability, with an Intra class Correlation Coefficient (ICC) often exceeding 0.90
Measured: 12th week
10-Meter Walk Test
The 10-Meter Walk Test involves timing a participant as they walk a distance of 10 meters at their comfortable pace. It assesses gait speed, which is an important indicator of mobility and overall functional ability.
Measured: 12th week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 May 2026
- Study start15 May 2026 (estimated)
- Primary completion15 Aug 2026 (estimated)
- Study completion30 Aug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Diabetic NeuropathiesStudies of the same condition, open and under way.
- More trials run by Riphah International UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 44 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Riphah International University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Javeria Ghazal, MS, Principal investigator, Riphah International University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07575126
- Sponsor's protocol ID
- REC/RCR &AHS/24/0297
- Status last verified
- May 2026
- First submitted
- 23 Feb 2026
- Last updated
- 8 May 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Qigong and Otago on Agility, Balance, Gait, and Quality of Life in Patients With Diabetic Neuropathy
- ClinicalTrials.gov ID
- NCT07575126
- Acronym / sponsor ID
- REC/RCR &AHS/24/0297
- Conditions
- Diabetic Neuropathies
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 44 participants (estimated)
- Lead sponsor
- Riphah International UniversityUniversity, hospital or other
- Study start
- 15 May 2026 (estimated)
- Primary completion
- 15 Aug 2026 (estimated)
- Study completion
- 30 Aug 2026 (estimated)
- First posted
- 8 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study seeks to compare these two interventions to better understand their impact on key health outcomes in patients affected by diabetic neuropathy, providing valuable insights for clinicians and healthcare providers managing this challenging condition
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Qigong Balance | Experimental | Other: Qigong Balance |
| Otago Balance | Active comparator | Other: Otago Balance |
Who may qualify
- Ages
- 45 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Physician-diagnosed type 2 diabetes without gender bias, with peripheral neuropathy (defined by Michigan Neuropathy Screening Instrument questionnaire score of 5 or greater)
- Type 2 diabetic peripheral neuropathy patients
- The ability to walk independently for 10 m
- Having score between 46 to 52 (out of a total of 56 points) on the BBS
Key exclusion criteria (6 listed)
- Fracture of the lower limb within the 6 months before the study (15)
- Diabetic ulcer, infection or partial amputation in feet (15)
- Disease or functional impairment of auditory, vestibular system (16)
- Any other medical conditions that would confound assessment of neuropathy such as malignancy, other neurological or orthopedic impairments (such as stroke, poliomyelitis, rheumatoid arthritis, prosthesis, or severe osteoarthritis), major vascular complications (venous or arterial ulcers), severe retinopathy, or severe nephropathy that causes edema or needs hemodialysis (17)
- Dementia or inability to give consistent information (18)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Qigong BalanceQuigong Balance Exercises 3 times per week for 60 minutes per session Open the Flow: Focus on fluid arm movements to enhance relaxation and improve circulation. Shaking Exercise: A full-body shake to release tension and promote energy flow. Lifting the Ball: Alternating arm movements simulating lifting a ball to improve upper body strength and coordination. Playing with Water: Slow, flowing movements that enhance balance and mindfulness. Weight Shifting and Balance Exercises: Stand with feet hip-width apart, shifting weight slowly from one leg to the other, holding each position for 10-15 seconds to engage stabilizing muscles in the legs and improve proprioception. Leg Lifts and Extensions: Perform controlled leg lifts (front, side, and back) to strengthen the quadriceps, hamstrings, and hip abductors. | Other | Qigong Balance |
| Otago BalanceOtago (Strengthening) Balance: Sit-to-stand exercises: to improve leg strength. Heel raises: to enhance calf strength. Toe stands: for improving foot stability. Balance Training: Single-leg stands: to enhance balance. Tandem walking: along a straight line. Side leg raises: to strengthen hip muscles 3 times per week for 60 minutes per session | Other | Otago Balance |
Primary outcome
Agility T-Test
Time frame: 12th week
The Agility T-Test is a performance-based assessment that measures an individual's agility and ability to change direction quickly. It involves a sequence where the participant runs to a designated point, makes sharp turns around markers in a T-shaped layout, and returns to the starting position.
Berg Balance Scale
Time frame: 12th week
is the gold standard test for static and dynamic balance abilities. The BBS is used to measure ability to maintain balance while doing functional task search as reach, standing position and transferences. It is a valid instrument used for the evaluation of effectiveness of interventions with quantitative description of function in clinical practice as well as research. It consists of 14 items including simple balance tasks from everyday life.
Functional Reach Test
Time frame: 12th week
FRT is a single item test for dynamic balance and acts as a quick screen for balance problems in older adults. The distance between the lengths of an outstretched arm in a maximal forward reach, while maintaining a fixed base of support is measured. A score of 6 inches or less indicates a significant increased risk for falls. A score between 6-10 inches indicates a moderate risk for falls. the Functional Reach Test (FRT) demonstrates an ICC of approximately 0.85 to 0.94
Gait Speed Test
Time frame: 12th week
The Gait Speed Test measures the time it takes for an individual to walk a specific distance, usually 10 meters, at their usual pace. It has demonstrated strong validity and reliability, with an Intra class Correlation Coefficient (ICC) often exceeding 0.90
10-Meter Walk Test
Time frame: 12th week
The 10-Meter Walk Test involves timing a participant as they walk a distance of 10 meters at their comfortable pace. It assesses gait speed, which is an important indicator of mobility and overall functional ability.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 May 2026.
- Individual participant dataSharing planned: No
Related trials for Diabetic Neuropathies
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Active, not recruiting
Wearable Insoles for Recurrent Diabetic Ulcer Prevention
Diabetes, Peripheral Neuropathy
Recruiting
Effect of 4-7-8 Breathing Technique on Pain and Anxiety During Electromyography in Diabetic Neuropathy
Diabetic Neuropathies, Diabetes Mellitus (Type 2)
Active, not recruiting
Evaluation of Personalized Nutritional Intervention on Wound Healing of Cutaneous Ulcers in Diabetics
Foot, Diabetic
Active, not recruiting
Comparative Effects Of Sensory Reweighting And Proprioceptive Facilitation Training On Balance And Fall Risk In Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathy (DPN)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Javeria Ghazal, MS principal investigator
Riphah International University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Qigong Balance and Otago Balance in people with Diabetic Neuropathies, run by Riphah International University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 8 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Muneeb Khan, PhD (+92336799611, muneeb.khan@riphah.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Agility T-Test (time frame: 12th week). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2026.